Literature DB >> 3391885

Increased resting energy expenditure in cystic fibrosis.

R M Buchdahl1, M Cox, C Fulleylove, J L Marchant, A M Tomkins, M J Brueton, J O Warner.   

Abstract

To explore the hypothesis that there is an increased metabolic rate in cystic fibrosis, resting energy expenditure was measured by indirect calorimetry in 23 subjects with cystic fibrosis in a stable clinical state and in 42 normal control subjects. Resting energy expenditure was found to be elevated by an average of 0.45 MJ/24 h [95% confidence interval (CI) = 0.26-0.64, t = 4.91, P less than 0.001] (108 kcal/24 h), or 9.2% above expected values derived from the regression relating resting energy expenditure to whole body weight and sex in control subjects. When related to lean body mass, values were still elevated by 0.36 MJ/24 h (95% CI = 0.18-0.53, t = 4.15, P less than 0.001) (86 kcal/24 h), or 7.2%. The increased values were found to be independent of age, sex, or body size. There were significant correlations between increased values and poor pulmonary function as measured by the ratio of the forced expiratory volume in 1 s to forced vital capacity (r = -0.44, P less than 0.05) and subclinical infection as indicated by the blood leukocyte count (r = 0.40, P less than 0.05). However, the correlations were low, suggesting that other factors may contribute to the increased resting energy expenditure, possibly including the putative metabolic defect in cystic fibrosis.

Entities:  

Mesh:

Year:  1988        PMID: 3391885     DOI: 10.1152/jappl.1988.64.5.1810

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  12 in total

1.  Increased energy expenditure in Parkinson's disease.

Authors:  S Levi; M Cox; M Lugon; M Hodkinson; A Tomkins
Journal:  BMJ       Date:  1990-12-01

Review 2.  Energy balance and growth in cystic fibrosis.

Authors:  S A Wootton; J L Murphy; S A Bond; J E Ellis; A A Jackson
Journal:  J R Soc Med       Date:  1991       Impact factor: 5.344

Review 3.  A rational approach to the nutritional care of patients with cystic fibrosis.

Authors:  P R Durie; P B Pencharz
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

4.  Percutaneous endoscopic gastrostomy feeding in patients with cystic fibrosis.

Authors:  S G Williams; F Ashworth; A McAlweenie; S Poole; M E Hodson; D Westaby
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

Review 5.  Subclinical colonic thickening.

Authors:  P J Oades; M Rosenthal; E J Mac Sweeney; A Bush
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

6.  Absence of leptin signaling allows fat accretion in cystic fibrosis mice.

Authors:  Ilya R Bederman; Gavriella Pora; Maureen O'Reilly; James Poleman; Kimberly Spoonhower; Michelle Puchowicz; Aura Perez; Bernadette O Erokwu; Alex Rodriguez-Palacios; Chris A Flask; Mitchell L Drumm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-08-17       Impact factor: 4.052

7.  Resting energy expenditure and substrate oxidation rates in cystic fibrosis.

Authors:  I M Bowler; J H Green; S P Wolfe; J M Littlewood
Journal:  Arch Dis Child       Date:  1993-06       Impact factor: 3.791

8.  Energy and nutrient intakes in cystic fibrosis.

Authors:  R M Buchdahl; C Fulleylove; J L Marchant; J O Warner; M J Brueton
Journal:  Arch Dis Child       Date:  1989-03       Impact factor: 3.791

9.  A double blind lipase for lipase comparison of a high lipase and standard pancreatic enzyme preparation in cystic fibrosis.

Authors:  I M Bowler; S P Wolfe; H M Owens; T A Sheldon; J M Littlewood; M P Walters
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

10.  Expression and localization of the cystic fibrosis transmembrane conductance regulator mRNA and its protein in rat brain.

Authors:  A E Mulberg; L P Resta; E B Wiedner; S M Altschuler; D M Jefferson; D L Broussard
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.